Focus specialises in bringing its portfolio of niche generic medicines to the market in the UK. Focus is part of the AMCo group and came under the ownership of Concordia International Corp in October 2015, through their acquisition of AMCo. Concordia is a diverse healthcare company focused on legacy pharmaceutical products and orphan drugs.

Discover more about…

Company latest

News and press

April 2015

Focus successful in UK litigation against Novartis concerning VolezeĀ® Rivastigmine Transdermal Patches